AT402822B - Sdk peptide, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen - Google Patents

Sdk peptide, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen Download PDF

Info

Publication number
AT402822B
AT402822B AT0053290A AT53290A AT402822B AT 402822 B AT402822 B AT 402822B AT 0053290 A AT0053290 A AT 0053290A AT 53290 A AT53290 A AT 53290A AT 402822 B AT402822 B AT 402822B
Authority
AT
Austria
Prior art keywords
lys
asp
ser
pro
boc
Prior art date
Application number
AT0053290A
Other languages
German (de)
English (en)
Other versions
ATA53290A (de
Inventor
Maryse Lenfant
Josiane Thierry
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of ATA53290A publication Critical patent/ATA53290A/de
Application granted granted Critical
Publication of AT402822B publication Critical patent/AT402822B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT0053290A 1989-03-11 1990-03-07 Sdk peptide, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen AT402822B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898905606A GB8905606D0 (en) 1989-03-11 1989-03-11 Peptides

Publications (2)

Publication Number Publication Date
ATA53290A ATA53290A (de) 1997-01-15
AT402822B true AT402822B (de) 1997-09-25

Family

ID=10653152

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0053290A AT402822B (de) 1989-03-11 1990-03-07 Sdk peptide, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen

Country Status (32)

Country Link
US (1) US5112811A (fr)
JP (1) JPH0347197A (fr)
KR (1) KR0133850B1 (fr)
AR (1) AR245139A1 (fr)
AT (1) AT402822B (fr)
AU (1) AU631197B2 (fr)
BE (1) BE1003996A3 (fr)
CA (1) CA2011874C (fr)
CH (1) CH680666A5 (fr)
DE (1) DE4007605B4 (fr)
DK (1) DK173932B1 (fr)
ES (1) ES2023746A6 (fr)
FI (1) FI901196A0 (fr)
FR (2) FR2644164A1 (fr)
GB (2) GB8905606D0 (fr)
GR (1) GR1000344B (fr)
HK (1) HK95392A (fr)
IE (1) IE64762B1 (fr)
IN (1) IN173870B (fr)
IT (1) IT1240933B (fr)
LU (1) LU87696A1 (fr)
MA (1) MA21770A1 (fr)
MY (1) MY106274A (fr)
NL (1) NL194918C (fr)
NO (1) NO901129L (fr)
NZ (1) NZ232815A (fr)
OA (1) OA09197A (fr)
PT (1) PT93380B (fr)
SE (1) SE9000793L (fr)
SG (1) SG91892G (fr)
TN (1) TNSN90027A1 (fr)
ZA (1) ZA901718B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK31991D0 (da) * 1991-02-25 1991-02-25 Carlbiotech Ltd As Peptid og farmaceutisk praeparat indeholdende et saadant peptid
GB9211668D0 (en) * 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
DE4224509C2 (de) * 1992-07-24 1995-04-20 Ruhenstroth Bauer Gerhard Prof Wirkstoff zur Hemmung der Proliferationsrate von Leberzellen
RU2302870C1 (ru) * 2006-06-22 2007-07-20 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Средство, обладающее геропротекторной активностью, и способ его получения

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000594A1 (fr) * 1986-07-18 1988-01-28 Institut National De La Sante Et De La Recherche M Tetrapeptide inhibiteur de l'entree en cycle des cellules souches hematopoietiques, procedes pour son obtention et ses applications

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US216088A (en) * 1879-06-03 Improvement in bale-ties
DE2602443A1 (de) * 1975-04-04 1976-10-21 Univ California Biologisch aktive polypeptide
US4816449A (en) * 1984-08-09 1989-03-28 Immunetech Pharmaceuticals Immunotherapeutic anti-inflammatory peptide agents
FR2565985B1 (fr) * 1984-06-19 1987-09-25 Rhone Poulenc Sante Nouvelles substances biologiquement actives obtenues a partir de la caseine bovine, leur procede de preparation et les compositions qui les contiennent
EP0200748B1 (fr) * 1984-10-15 1991-02-06 Cetus Corporation Facteur de necrose de tumeurs humaines
FR2622587B1 (fr) * 1987-10-30 1990-12-21 Inst Vaisseaux Sang Peptide lysyl-arginyl-aspartyl-serine et ses applications en tant que medicament, notamment antithrombotique
JPH0742313B2 (ja) * 1988-03-28 1995-05-10 日立化成工業株式会社 新規ペプチド、その塩及びペプチド性抗アレルギー剤

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000594A1 (fr) * 1986-07-18 1988-01-28 Institut National De La Sante Et De La Recherche M Tetrapeptide inhibiteur de l'entree en cycle des cellules souches hematopoietiques, procedes pour son obtention et ses applications

Also Published As

Publication number Publication date
ES2023746A6 (es) 1992-02-01
DE4007605A1 (de) 1990-09-13
MY106274A (en) 1995-04-29
JPH0347197A (ja) 1991-02-28
ATA53290A (de) 1997-01-15
GB8905606D0 (en) 1989-04-26
OA09197A (fr) 1992-06-30
MA21770A1 (fr) 1990-10-01
GB2228937B (en) 1992-07-08
IN173870B (fr) 1994-07-30
NO901129L (no) 1990-09-12
NO901129D0 (no) 1990-03-09
KR0133850B1 (ko) 1998-04-21
FR2644065A1 (fr) 1990-09-14
GB9005069D0 (en) 1990-05-02
IT1240933B (it) 1993-12-27
BE1003996A3 (fr) 1992-09-08
HK95392A (en) 1992-12-04
GR900100164A (en) 1990-07-31
SG91892G (en) 1992-12-04
SE9000793D0 (sv) 1990-03-06
CA2011874A1 (fr) 1990-09-11
DK62690D0 (da) 1990-03-09
NL9000551A (nl) 1990-10-01
DK62690A (da) 1990-09-12
FR2644164B1 (fr) 1995-03-17
IT9019630A1 (it) 1991-09-09
IT9019630A0 (it) 1990-03-09
CH680666A5 (en) 1992-10-15
AR245139A1 (es) 1993-12-30
GB2228937A (en) 1990-09-12
ZA901718B (en) 1990-12-28
US5112811A (en) 1992-05-12
AU631197B2 (en) 1992-11-19
DE4007605B4 (de) 2006-03-23
SE9000793L (sv) 1990-09-12
IE64762B1 (en) 1995-09-06
PT93380A (pt) 1990-11-07
KR900014426A (ko) 1990-10-23
NL194918B (nl) 2003-03-03
LU87696A1 (fr) 1990-07-24
PT93380B (pt) 1997-01-31
TNSN90027A1 (fr) 1991-03-05
FR2644164A1 (fr) 1990-09-14
GR1000344B (el) 1992-06-25
CA2011874C (fr) 1998-07-21
AU5117590A (en) 1990-09-13
DK173932B1 (da) 2002-02-25
FI901196A0 (fi) 1990-03-09
IE900850L (en) 1990-09-11
NZ232815A (en) 1992-06-25
FR2644065B1 (fr) 1994-10-07
NL194918C (nl) 2003-07-04

Similar Documents

Publication Publication Date Title
US4612365A (en) Medicaments containing alpha 1-thymosin and having an immuno regulatory action and alpha 1-thymosin fragments
US4910296A (en) Medicaments containing alpha 1 thymosin fragments and having an immunostimulant action, and fragments of alpha 1 thymosin
EP0067425B1 (fr) Peptides éventuellement protégés, leur procédé de préparation et compositions pharmaceutiques les contenant
EP0026464A2 (fr) Peptides, leur préparation, leur utilisation et compositions pharmaceutiques
EP0014815A2 (fr) Dérivés peptidiques, procédé pour leur préparation et intermédiaires, et compositions pharmaceutiques contenant un de ces composés
SK281825B6 (sk) Peptidy a spôsob ich prípravy
AT402822B (de) Sdk peptide, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
Hsieh et al. Angiotensin II analogs. 14. Roles of the imidazole nitrogens of position-6 histidine in pressor activity
EP0033384B1 (fr) Médicaments contenant des fragments de thymosine-alpha-1, leur activité immunostimulante, et fragments de thymosine-alpha-1
DE2804566A1 (de) Polypeptide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
EP0080194B1 (fr) Peptides et leur procédé de préparation
DE3712090C2 (fr)
EP0056594B1 (fr) Fragments de thymosine alpha-1 et compositions pharmaceutiques à action immunorégulatrice qui les contiennent
DE3712050C2 (fr)
EP0307553B1 (fr) Splénopentines modifiées, leur procédé de préparation et leur emploi
CH640217A5 (en) Polypeptides, their preparation and pharmaceutical preparations
CH654841A5 (de) Appetitzuegelnde tripeptide und verfahren zur herstellung derselben.
NO854788L (no) Vekstfremmende middel for dyr.
DE2617202A1 (de) Oligopeptide als komplementhemmer
CS228546B2 (cs) Způsob výroby pentapeptidů
WO1991015508A1 (fr) Derives de splenopentine humaine et procede pour leur fabrication

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee